Sign in
4

Changes in Ownership

REGENERON PHARMACEUTICALS, INC. Filed Acc 0002009236-26-000003

SVP Controller sold 4,062 shares at an average $942.19 ($3,827,159)

  • SVP Controller acquired 3,883 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Pitofsky Jason · SVP Controller

Table I: Non-derivative

11 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-04 Exercise or conversion : show line 1 in the form +1,500 $726.53 $1,089,795 5,772 D
2026-11-04 Exercise or conversion : show line 2 in the form +1,478 $644.54 $952,630 7,250 D
2026-11-04 Exercise or conversion : show line 3 in the form +905 $492.00 $445,260 8,155 D
2026-11-04 Sale : show line 4 in the form −439 $939.57 $412,471 7,716 D
2026-11-04 Sale : show line 5 in the form −575 $940.46 $540,765 7,141 D
2026-11-04 Sale : show line 6 in the form −982 $941.58 $924,632 6,159 D
2026-11-04 Sale : show line 7 in the form −1,215 $942.31 $1,144,907 4,944 D
2026-11-04 Sale : show line 8 in the form −529 $943.53 $499,127 4,415 D
Open-market sales · 4,062 sh · avg $942.19 · $3,827,159

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2026-11-04 Exercise or conversion : show line 12 in the form Non-Qualified Stock Option (right to buy) −905 0 D
2026-11-04 Exercise or conversion : show line 13 in the form Non-Qualified Stock Option (right to buy) −1,478 500 D
2026-11-04 Exercise or conversion : show line 14 in the form Non-Qualified Stock Option (right to buy) −1,500 2,478 D
Loading xslF345X06/edgardoc.xml…